Johnson & Johnson Profit Margin

Johnson & Johnson posts a profit margin of 16.12% as of September 2026. That compares with 36.72% in the prior-year period — down 56.1% year over year. That is above the Healthcare sector average of 9.48%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Johnson & Johnson's profit margin was 36.72%. The latest reading is 16.12% — a 56.1% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.48% is typical. Johnson & Johnson's 16.12% is higher that level. That is roughly 70.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Johnson & Johnson's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 16.12% as of September 2026; use YoY and peer views to separate noise from signal.

Context for JNJ.DE's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.48%), and (3) consistency with growth and profitability. This page covers the first two; Johnson & Johnson's other metric pages and overview cover the third.